Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04795635 · ClinicalTrials.gov registry record · NA
Axon Therapy for Post-Traumatic Peripheral Neuropathic Pain Compared to Conventional Medical Management
A NA study of Neuropathic Pain and Peripheral Neuropathy, sponsored by NeuraLace Medical.
- Active
- Registry status
- NA
- Development phase
- 61
- Enrollment target
- 3
- Study locations
NCT04795635: Active NA study of Neuropathic Pain and Peripheral Neuropathy, sponsored by NeuraLace Medical.
NCT04795635 is a NA study of Neuropathic Pain and Peripheral Neuropathy that is active but no longer recruiting, run by NeuraLace Medical. The registered enrollment target is 61 participants, below the 99-participant average among 35 other Neuropathic Pain trials with a reported enrollment target (38% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04795635, a NA study of Neuropathic Pain and Peripheral Neuropathy, is active but no longer recruiting, sponsored by NeuraLace Medical.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 61 participants
- Enrollment target
- 3
- Study locations
Study Summary
Compare Axon Therapy using transcutaneous magnetic stimulation (tMS) against conventional medical management in treating post-traumatic peripheral neuropathic pain (PTPNP).
Conditions Studied
Interventions
- DEVICE CMM + Axon Therapy
Study Locations (3)
New Jersey
- National Spine and Pain Centers - Shrewsbury
North Carolina
- Carolinas Pain Institute - Winston-Salem
South Carolina
- SC Pain and Spine Specialists (Crescent Moon Research Corp) - Murrells Inlet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 61 participants |
| Start Date | 2021-04-14 |
| Est. Completion | 2024-08-22 |
| Phase | NA |
What the registry record for NCT04795635 still lists
NCT04795635 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 61 participants, a relatively small participant target, below the 99-participant average among 35 other Neuropathic Pain trials with a reported enrollment target (38% lower).
The record links to 2 conditions, with Neuropathic Pain appearing as the primary indexed condition, and to 1 intervention - of which CMM + Axon Therapy is the first listed.
NCT04795635 reports a single indexed study location in New Jersey, North Carolina, South Carolina.
Frequently Asked Questions
What is clinical trial NCT04795635 about?
NCT04795635 is a clinical study titled "Axon Therapy for Post-Traumatic Peripheral Neuropathic Pain Compared to Conventional Medical Management". Compare Axon Therapy using transcutaneous magnetic stimulation (tMS) against conventional medical management in treating post-traumatic peripheral neuropathic pain (PTPNP).
What is the current status of trial NCT04795635?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 61 participants. The study started on 2021-04-14. Estimated completion is 2024-08-22.
What conditions does trial NCT04795635 study?
This clinical trial studies the following conditions: Neuropathic Pain, Peripheral Neuropathy.
What interventions are being tested in trial NCT04795635?
The interventions under investigation include: CMM + Axon Therapy (DEVICE).
Who is sponsoring clinical trial NCT04795635?
This trial is sponsored by NeuraLace Medical, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04795635 being conducted?
This trial has 3 study locations across New Jersey, North Carolina, South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Neuropathic Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04795635's enrollment target sits among peer trials
61 12th of 35 higher than 24 of 35 other Neuropathic Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Neuropathic Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Virtual Reality (VR) Self-Hypnosis Software
RECRUITING · NA
-
Neuropathic Pain and Operant Conditioning of Cutaneous Reflexes After SCI
RECRUITING · NA
-
Utility of Multisensory Body-Representation in Spinal Cord Injury (SCI) With Pain
RECRUITING · NA
-
Virtual Walking Intervention for Neuropathic Pain in Spinal Cord Injury
RECRUITING · NA
-
Virtual Walking Therapy for Neuropathic Pain Following Incomplete Spinal Cord Injury
RECRUITING · NA
-
Insula Neuromodulation for Chronic Neuropathic Pain
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04115306 · 61 participants · Phase 1
Phase 1/1b/2 Study of Oral PMD-026 in Patients With Metastatic Breast Cancer
- NCT05070845 · 61 participants · Phase 2
Safety and Efficacy Study of PF-06835375 in Primary Immune Thrombocytopenia
- NCT05187832 · 61 participants · Phase 1
A Study of AND019 in Women With ER Positive HER2 Negative Advanced or Metastatic Breast Cancer
- NCT05269316 · 61 participants · Phase 1
Study to Evaluate IMP9064 as a Monotherapy or in Combination in Patients With Advanced Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI